New drug MIB-725 gets first safety check in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study tests a new drug called MIB-725 in 32 healthy adults aged 19 to 60. Participants receive a single dose (100 to 800 mg) and are monitored for side effects and how the drug moves through the body. The goal is to see if the drug is safe before testing it in pe…
Phase: PHASE1 • Sponsor: Metro International Biotech, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC